Funds holding Lincoln Pharmaceuticals Ltd
ISIN INE405C01035 · India · LEI 3358004B6OBJNW8RTT10
- Fund holders
- 8
- Of which ETFs
- 5 3 other funds
- Value held
- 384.4K $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Avantis Emerging Markets Equity ETF American Century ETF Trust | 19,446 | 135K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 17,425 | 118.8K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust | 10,298 | 70.1K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust | 5,504 | 37.4K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 1,483 | 10.1K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis Emerging Markets Equity Fund American Century ETF Trust | 1,473 | 10.2K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Emerging Markets Small Cap Equity ETF American Century ETF Trust | 377 | 2.6K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Emerging Markets ex-China Equity ETF American Century ETF Trust | 32 | 222.1 $ | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Avantis Emerging Markets Small Cap Equity ETF American Century ETF Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Emerging Markets Equity Fund American Century ETF Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis Emerging Markets Equity ETF American Century ETF Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis Emerging Markets ex-China Equity ETF American Century ETF Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 8 | -1 | 56,038 | +3.7 % |
| 2026Q1 | 9 | -2 | 54,029 | -8.6 % |
| 2025Q4 | 11 | 0 | 59,101 | +13.4 % |
| 2025Q3 | 11 | -1 | 52,114 | -6.8 % |
| 2025Q2 | 12 | +1 | 55,903 | +12.6 % |
| 2025Q1 | 11 | +3 | 49,641 | +13.5 % |
| 2024Q4 | 8 | +2 | 43,732 | +11.2 % |
| 2024Q3 | 6 | +2 | 39,342 | +46.5 % |
| 2024Q2 | 4 | +2 | 26,859 | +33.3 % |
| 2024Q1 | 2 | +1 | 20,153 | +214.9 % |
| 2023Q4 | 1 | 6,400 |
Cite this page
Titelia. "Funds holding Lincoln Pharmaceuticals Ltd". https://titelia.com/en/stocks/lincoln-pharmaceuticals-ltd-INE405C01035